Tuesday, 3 January 2012
Human trials for HIV vaccine get under way
The vaccine candidate will be formulated with an adjuvant - GLA - developed to enhance immune responsiveness following intramuscular injection. GLA formulations have been previously tested clinically with promising results. The scientists have enrolledThe GLA sees the potential for many
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment